SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 185 filers reported holding SAGE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $431,000 | -67.4% | 13,030 | +56.6% | 0.00% | -71.4% |
| Q1 2019 | $1,323,000 | +495.9% | 8,321 | +430.0% | 0.01% | +600.0% |
| Q3 2018 | $222,000 | -98.4% | 1,570 | -98.2% | 0.00% | -98.7% |
| Q2 2018 | $13,971,000 | +178.1% | 89,256 | +186.2% | 0.08% | +175.0% |
| Q1 2018 | $5,023,000 | +883.0% | 31,187 | +906.0% | 0.03% | +833.3% |
| Q4 2017 | $511,000 | +137.7% | 3,100 | -10.1% | 0.00% | +200.0% |
| Q3 2017 | $215,000 | +3.4% | 3,450 | -49.9% | 0.00% | -50.0% |
| Q2 2016 | $208,000 | – | 6,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |